These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1980465)

  • 21. Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography.
    Farthing D; Brouwer KL; Fakhry I; Sica D
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):350-3. PubMed ID: 9061475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies.
    Yeh KC; Chremos AN; Lin JH; Constanzer ML; Kanovsky SM; Hucker HB; Antonello J; Vlasses P; Ryan JR; Williams RL
    Biopharm Drug Dispos; 1987; 8(6):549-60. PubMed ID: 2892544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
    Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of famotidine in man.
    Kroemer H; Klotz U
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranitidine suspension or famotidine resoriblette and gastric fluid volume and pH.
    Oikkonen M; Erkola O; Collan R
    Can J Anaesth; 1995 Sep; 42(9):793-6. PubMed ID: 7497560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate.
    Koch KM; Davis IM; Gooding AE; Yin Y
    Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta.
    Dicke JM; Johnson RF; Henderson GI; Kuehl TJ; Schenker S
    Am J Med Sci; 1988 Mar; 295(3):198-206. PubMed ID: 2895583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranitidine reduces ischemia/reperfusion-induced liver injury in rats by inhibiting neutrophil activation.
    Okajima K; Harada N; Uchiba M
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1157-65. PubMed ID: 12023551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
    Scarpignato C; Tramacere R; Zappia L
    Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2717-22. PubMed ID: 11545397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells.
    Sewing KF; Hannemann H
    Pharmacology; 1986; 33(5):274-8. PubMed ID: 2432626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of H2-receptor blockade on gastric mucus composition. A comparative study with ranitidine and famotidine.
    Guslandi M; Testoni PA; Masci E
    J Int Med Res; 1987; 15(4):224-6. PubMed ID: 2888693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validated HPLC method for the determination of ranitidine in human serum and its application in a clinical pharmacokinetic study.
    Kumar MK; Jayasagar G; Chandrasekhar K; Ashok T; Rao YM
    Pharmazie; 2003 Apr; 58(4):284-5. PubMed ID: 12749414
    [No Abstract]   [Full Text] [Related]  

  • 37. [I.v. famotidine versus i.v. ranitidine: intragastric pH behavior in surgical intensive care patients].
    Friedl W; Krier C; Dammann HG; Müller P; Simon B
    Z Gastroenterol; 1985 Nov; 23(11):603-7. PubMed ID: 2868579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.
    Delhotal-Landes B; Flouvat B; Liote F; Abel L; Meyer P; Vinceneux P; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):442-52. PubMed ID: 2901930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
    Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH
    World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
    Ostro MJ
    Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.